| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M L De Ceballos, S Boyce, P Jenner, C D Marsde. Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats. European journal of pharmacology. vol 130. issue 3. 1987-02-11. PMID:3792452. |
alterations in [met5]- and [leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats. |
1987-02-11 |
2023-08-11 |
rat |
| A Kuruvilla, R Cherian, D R Theodore, J Abraha. Temporal profile of tissue levels of dopamine and its metabolites, HVA and DOPAC following focal cerebral ischaemia in anaesthetized primates. Clinical and experimental pharmacology & physiology. vol 13. issue 7. 1987-01-28. PMID:3791706. |
occlusion of the middle cerebral artery produced ischaemia and consequent changes in basal ganglia in the primate model of stroke within 0.5 h. dopamine content was decreased in the right basal ganglia from 0.5 h up to 12 h after occlusion. |
1987-01-28 |
2023-08-11 |
Not clear |
| M B Youdi. Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease. Journal of neural transmission. Supplementum. vol 22. 1987-01-20. PMID:3097263. |
although not all features of its anti-parkinson action is known, studies on brains obtained at autopsy from patients on (-)deprenyl show that the selective inhibition of mao b with a concomitant increase of dopamine, but not of serotonin, in the basal ganglia may be responsible for its mode of action. |
1987-01-20 |
2023-08-11 |
Not clear |
| D F Wong, H N Wagner, L E Tune, R F Dannals, G D Pearlson, J M Links, C A Tamminga, E P Broussolle, H T Ravert, A A Wilson, J K Toung, J Malat, J A Williams, L A O'Tuama, S H Snyder, M J Kuhar, A Gjedd. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (New York, N.Y.). vol 234. issue 4783. 1987-01-12. PMID:2878495. |
in postmortem studies of patients with schizophrenia, d2 dopamine receptors in the basal ganglia have been observed to be more numerous than in patients with no history of neurological or psychiatric disease. |
1987-01-12 |
2023-08-11 |
human |
| T Beck, J Krieglstei. The effects of tifluadom and ketazocine on behaviour, dopamine turnover in the basal ganglia and local cerebral glucose utilization of rats. Brain research. vol 381. issue 2. 1986-11-20. PMID:3756508. |
the effects of tifluadom and ketazocine on behaviour, dopamine turnover in the basal ganglia and local cerebral glucose utilization of rats. |
1986-11-20 |
2023-08-11 |
rat |
| R A Lyon, M Titeler, J J Frost, P J Whitehouse, D F Wong, H N Wagner, R F Dannals, J M Links, M J Kuha. 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 6. issue 10. 1986-11-12. PMID:2944994. |
3h-3-n-methylspiperone labels d2 dopamine receptors in basal ganglia and s2 serotonin receptors in cerebral cortex. |
1986-11-12 |
2023-08-11 |
human |
| S J Kish, A Rajput, J Gilbert, B Rozdilsky, L J Chang, K Shannak, O Hornykiewic. Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss. Annals of neurology. vol 20. issue 1. 1986-09-17. PMID:2874765. |
this secondary change in striatal gaba function is likely to contribute to the basal ganglia dysfunction produced by the striatal dopamine loss and thus may be related to certain aspects of parkinsonian symptomatology. |
1986-09-17 |
2023-08-11 |
human |
| A Camus, F Javoy-Agid, A Dubois, B Scatto. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine. Brain research. vol 375. issue 1. 1986-08-04. PMID:3719352. |
the present data indicate that [3h]npa is a suitable ligand for accurate autoradiographic labeling of dopamine d2 receptors in human postmortem brain tissue and that dopamine receptors are heterogeneously distributed and topographically organized in patches and gradients in the basal ganglia regions. |
1986-08-04 |
2023-08-11 |
human |
| J H Carlson, D A Bergstrom, J R Walter. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. European journal of pharmacology. vol 123. issue 2. 1986-06-27. PMID:2940101. |
the putatively selective d-1 dopamine receptor antagonist sch 23390 was used to study the role of the d-1 dopamine receptor in mediating the pre- and postsynaptic effects of dopamine agonists in the basal ganglia. |
1986-06-27 |
2023-08-11 |
Not clear |
| M J Bannon, J M Lee, P Giraud, A Young, H U Affolter, T I Bonne. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. The Journal of biological chemistry. vol 261. issue 15. 1986-06-19. PMID:2422168. |
tachykinin interaction with dopamine neurons may play an important role in the modulation of basal ganglia function. |
1986-06-19 |
2023-08-11 |
rat |
| A A Baumeister, G D Fry. The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome. Neuroscience and biobehavioral reviews. vol 9. issue 2. 1985-08-13. PMID:3925393. |
current evidence suggests that the primary neural deficit in the lesch-nyhan syndrome is a deficiency of dopamine in the basal ganglia. |
1985-08-13 |
2023-08-11 |
Not clear |
| C A Altar, H Kim, J F Marshal. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol. The Journal of pharmacology and experimental therapeutics. vol 233. issue 2. 1985-07-02. PMID:3889277. |
computer imaging and analysis of dopamine (d2) and serotonin (s2) binding sites in rat basal ganglia or neocortex labeled by [3h]spiroperidol. |
1985-07-02 |
2023-08-11 |
rat |
| G Bartholin. GABA receptor agonists: pharmacological spectrum and therapeutic actions. Medicinal research reviews. vol 5. issue 1. 1985-04-29. PMID:2984490. |
gaba receptor agonists decrease dopamine turnover in the basal ganglia and antagonize neuroleptic-induced increase in dopamine release. |
1985-04-29 |
2023-08-11 |
human |
| M Carli, J L Evenden, T W Robbin. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature. vol 313. issue 6004. 1985-04-02. PMID:3974701. |
these disabilities, which can induce visuospatial impairment and visual 'neglect', may also have a bearing on the controversy about the normal functions of the nigrostriatal dopamine (da) projection and the basal ganglia. |
1985-04-02 |
2023-08-11 |
rat |
| C Reavill, P Jenner, C D Marsde. Gamma-aminobutyric acid and basal ganglia outflow pathways. Ciba Foundation symposium. vol 107. 1985-01-24. PMID:6094124. |
manipulation of gaba function in outflow zones in the rat can produce catalepsy, locomotor hyperactivity, stereotypy or circling behaviour, so mimicking the effect of altered dopamine function within basal ganglia. |
1985-01-24 |
2023-08-12 |
rat |
| W W She. Extrapyramidal symptoms associated with alcohol withdrawal. Biological psychiatry. vol 19. issue 7. 1984-11-21. PMID:6477989. |
symptoms may be due to the reduction of dopamine in basal ganglia while withdrawing from alcohol. |
1984-11-21 |
2023-08-12 |
Not clear |
| D A Bergstrom, J R Walter. Dopamine attenuates the effects of GABA on single unit activity in the globus pallidus. Brain research. vol 310. issue 1. 1984-11-19. PMID:6478240. |
these results suggest that one way in which dopamine and dopamine agonists may affect basal ganglia function is by modulating gabaergic transmission in the globus pallidus. |
1984-11-19 |
2023-08-12 |
Not clear |
| G Bartholin. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist. Psychoneuroendocrinology. vol 9. issue 2. 1984-10-24. PMID:6089242. |
in the basal ganglia, gaba receptor agonists reduce dopamine turnover and potentiate the cataleptogenic action of neuroleptics. |
1984-10-24 |
2023-08-12 |
rat |
| V P Barkhatova, E I Kandel', T M Omorova, E G Demin. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). vol 84. issue 7. 1984-10-12. PMID:6382885. |
the level of homovanillic acid (hva) in the cerebrospinal fluid (csf) as an indicator of the cerebral metabolism of dopamine was examined prior to and after the stereotaxic operation on the basal ganglia in 13 patients with extrapyramidal hyperkinetic syndromes. |
1984-10-12 |
2023-08-12 |
Not clear |
| S J Kish, K S Shannak, A H Rajput, J J Gilbert, O Hornykiewic. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of neurology. vol 41. issue 6. 1984-06-21. PMID:6721735. |
although the main symptoms of parkinson's disease are primarily caused by disturbed basal ganglia (dopamine) function, cerebellar dysfunction related to norepinephrine may contribute to some abnormalities of motor performance in this disorder. |
1984-06-21 |
2023-08-12 |
human |